期刊文献+

非那雄胺在晚期前列腺癌治疗中的作用 被引量:3

The Function of Finasteride on Patients with Advanced Prostate Cancer
原文传递
导出
摘要 目的:探讨非那雄胺加间歇性雄激素阻断在晚期前列腺癌治疗中的作用。方法:将33例T_3期或T_4期前列腺癌患者分为两组,A组18例采用比卡鲁胺加戈舍瑞林,间歇性雄激素阻断治疗;B组15例采用非那雄胺加比卡鲁胺加戈舍瑞林治疗。间歇期内B组继续服用非那雄胺。结果:治疗后9个月,A组13例完全缓解,3例部分缓解,2例无变化,有效率为88.9%。前列腺特异性抗原(PSA)为0.3~37.3 ng/ml,平均(7.6±6.5)ng/ml。B组12例完全缓解,2例部分缓解,1例无变化,有效率为93.3%。PSA为0.1~10.5 ng/ml,平均(4.2±2.8)ng/ml。B组PSA值低于A组,差异有统计学意义(P<0.05)。随访61.7(31~82)个月,B组停药间期(25.1±10.1)个月长于A组(15.7±8.6)个月(P<0.05)。A组5年生存率为55.6%(10/18),B组为66.7%(10/15),差异无统计学意义(P>0.05)。治疗后5年,A组仍有6例有效(33.3%),B组8例有效(53.3%),差异无统计学意义(P>0.05)。结论:非那雄胺加上间歇性雄激素阻断治疗,能使晚期前列腺癌PSA进一步降低,停药间期延长。 Objective:To observe the effect of finasteride plus intermittent androgen blockade (IAB) on pa tients with advanced prostate cancer. Methods:A total of 33 patients with T3 T4 prostate cancer were observed. 18 patients(group A) were treated with IAB(bicalutamide and Goserelin). 15 patients( group B) were treated with IAB plus finasteride. In the time off treatment, patients in group B were treated with finasteride continuously. Resuits:9 months latter, 13 cases obtained complete remission, 3 cases obtained partial remission, 2 cases no change in group A. 12 cases'obtained complete remission, 2 cases obtained partial remission, 1 case no change in group B. The serum prostate specific antigen (PSA) level was higher significantly in group A (0.3 37.3 ng/ml, average 7.6±6.5 ng/ml) than that in group B(0. 1-10.5 ng/ml, average 4.2±218 ng/ml )(P〈0.05) . 33 cases were followed up from 31 to82 months(average 61.7 months). The time off treatment was longer significantly in group B (25. 1±10.1 months) than that in group A(15.7±8.6 months) (P〈0.05). 5 year survival rate of group A was 55 . 6% (10/18), Bgroup was 66 . 7% (10/15). The difference was not statistically significant ( P 〉 0. 05). 6 cases still maintained effective in group A(33.3%) and 8 cases in group B(53.3%) 5 years latter after treatment(P〉0.05). Conclusions:Compared with lAB monotherapy, the treatment of IAB plus finasteride can de crease serum PSA level obviously, extend time off treatment.
出处 《临床泌尿外科杂志》 北大核心 2009年第11期854-855,858,共3页 Journal of Clinical Urology
关键词 前列腺肿瘤 非那雄胺 间歇性雄激素阻断 prostate neoplasm finasteride intermittent androgen blockade
  • 相关文献

参考文献11

  • 1Thompson I M, Goodman P J, Tangen C M, et al The influence of finasteride on the development of prostare cancer[J]. N Engl J Med, 2003, 349(3): 215- 224.
  • 2Thomas L N, Douglas R C, Lazier C B, et al. Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer[J]. J Urol, 2008, 179(1) :147-151.
  • 3Festuccia C, Angelucci A, Gravina G L, et al. Effects of 5 alpha reductase inhibitors on androgen dependent human prostatic carcinoma cells[J]. J Cancer Res Clin Oncol, 2005,131(4) :243--254.
  • 4Festuccia C, Gravina G L, Muzi P, et al. Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386[J]. J Urol, 2008, 180(1) :367-372.
  • 5Cho Y M, Takahashi S, Asamoto M, et al. Suppressive effects of antiandrogens, finasteride and flutamide on development of prostatic lesions in a transgenic rat model[J]. Prostate Cancer Prostatic Dis, 2007, 10(4): 378--383.
  • 6Tay M H, Kaufman D S, Regan M M, et al. Finas teride and hicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate [J]. Ann Oncol, 2004(15):974-978.
  • 7Oh W K, Manola J, Bittmann L, et al. Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up[J]. Urology, 2003,62(1):99-104.
  • 8Barqawi A B, Moul J W, Ziada A, et al. Combination of low dose flutamide and finasteride for PSA only recurrent prostate cancer after primary therapy[J]. Urology, 2003,62(5): 872--876.
  • 9Golbano J M, Loppez-Aparicio P, Recio M N, et al. Related Articles, Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase 3 proteins in LNCaP human prostate cancer cell line[J].Int J Oncol, 2008,32(4):919--924.
  • 10Bass R, Perry B, Langenstroer P, et al. Effects of short term finasteride on apoptotic factors and androgen receptors in prostate cancer cells[J]. J Urol, 2009, 181 (2): 615-619.

二级参考文献10

  • 1Tay MH, Kaufman DS, Regan MM, et al. Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate. Ann Oncol,2004,15:974-978.
  • 2Thompson IM,Goodman PJ,Tangen CM,et al. The influence of finasteride on the development of prostate cancer. N Engl J Med,2003,349:215-224.
  • 3Pareek G, Shevchuk M, Armenakas NA, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol,2003,169:20-23.
  • 4Semenza GL. HIF-1 and tumor progression :pathophysiology and therapeutics. Trends Mol Med, 2002,8:62-67.
  • 5Zhong H, De Marzo AM, Laughner E,et al. Overexpression of hypoxia-inducible factor lαin common human cancers and their metastases. Cancer Res, 1999,59:5830-5835.
  • 6Zhong H, Semenza GL, Simons JW, et al. Up-regulation of hypoxiainducible factor 1 alpha is an early event in prostate carcinogenesis.Cancer Detect Prev,2004,28:88-93.
  • 7Gao N,Ding M,Zheng JZ,et al. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem ,2002,277:31963-31971.
  • 8Gao N, Jiang BH, Leonard SS, et al. p38 Signaling-mediated hypoxiainducible factor 1 alpha and vascular endothelial growth factor induction by Cr(Ⅵ) in DU145 human prostate carcinoma cells. J Biol Chem ,2002,277:45041-45048.
  • 9Mabjeesh NJ,Willard MT,Frederickson CE,et al. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3 '-kinase/protein kinase Bin prostate cancer cells. Clin Cancer Res,2003,9:2416-2425.
  • 10平浩,陈晓春,王辉,陈朝晖,曾甫清,鲁功成.缺氧诱导因子-1α在前列腺癌中的表达及意义[J].中华泌尿外科杂志,2004,25(2):88-90. 被引量:10

共引文献2

同被引文献22

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部